advertisement
The UK has become the first country to approve the Pfizer/BioNTech vaccine for widespread use. The government has ordered 40 million doses and the first batch of 800,000 doses is expected to be shipped from Belgium – where the vaccine is being made – in the next couple of days. It will be enough to immunise 400,000 people (two doses per person).
The UK drugs regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), is also started a rolling review of other vaccines in late-stage human trials, such as the AstraZeneca/Oxford vaccine and the Moderna vaccine.
If these vaccines also meet the very high efficacy and safety standards set by the agency, they too will be approved for mass rollout.
The MHRA has pored over the records of over 40,000 vaccine trial participants from diverse backgrounds. The efficacy of the vaccine – that is, how effective it is at preventing symptomatic COVID-19 under trial conditions – is 95 percent. (That figure is expected to fall slightly under real-world conditions.)
It is expected that healthcare workers will receive the vaccine first as they are one of the most vulnerable groups. Also, hospitals have the ultra-cold freezers needed to store the vaccine – so, from a logistics standpoint, it’s a good place to start.
This is all fantastic news and a good reason to be optimistic about the future. But Peter Openshaw, a professor of experimental medicine at Imperial College London, said it would be a “terrible mistake” to ease up on COVID control measures at this juncture.
So, don’t throw away your mask and hug your gran just yet. A report from The Royal Society, the world’s oldest independent scientific academy, says that restrictions are likely to remain in place for some months yet – maybe even a year.
The response from your immune system, generated by the B lymphocytes, is known as the primary response and it takes about two weeks to kick in. So, for two weeks after getting the jab you are still at risk of getting ill from COVID.
Also, many COVID vaccines require two jabs to provide full protection. And the interval between the jabs varies from 21 to 28 days. So, the vaccine will take about six weeks after the first jab to provide full protection against COVID-19 disease.
Although the vaccines in late-stage trials seem to be highly effective at preventing symptomatic COVID, we can’t yet be sure that they prevent transmission of the virus.
So, even six weeks after receiving the first jab, you may still get infected with the coronavirus – even if you don’t get sick.
Studies from the preclinical phase of the Oxford vaccine found that rhesus macaques that were immunised with the vaccine were protected from serious disease and had no evidence of lung damage.
But they still had coronavirus infection in their upper-respiratory tract and virus shedding from their noses. If this is the same with humans, it would suggest that while they will be protected from symptomatic disease, they might still spread the virus.
Also, if you have been vaccinated, there is a small chance – at least one in twenty – that the vaccine won’t protect you. So, even if you have been vaccinated – and full rollout may not be complete till the summer of 2021 – you should still wear a mask, work from home if you can, and practice social distancing.
As for good hand hygiene, let’s try to keep that going – viruses, including probably SARS-CoV-2, will always be among us.
(This is an opinion piece and the views expressed above are the author’s own. The Quint neither endorses nor is responsible for the same. This article was originally published on The Conversation. Read the original article here.)
(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)
Published: 03 Dec 2020,05:12 PM IST